Weakness in the legacy microfluidics business is offsetting the company's best growth opportunity. What needs to happen for that to change?
News & Analysis: Fluidigm
The company reported second-quarter revenue at the low end of its expectations and well below the average Wall Street estimate.
FLDM earnings call for the period ending June 30, 2019.
The decision to retire $150 million in convertible debt caught the market off guard, but the business made progress on its long-term goals.
The laboratory equipment manufacturer announced first-quarter 2019 operating results and a significant transaction.
FLDM earnings call for the period ending March 31, 2019.
Can the laboratory equipment supplier keep up the momentum from a solid operational performance in 2018?
The sleepy laboratory hardware manufacturer has found itself on the radar of many investors lately.
The low-priced shares could be bargain-bin buys.
Wall Street analysts aren't paying enough attention to Qutoutiao, TransDigm Group, and Fluidigm.